Ownership and insider activity for Lunai Bioworks Inc. (LNAI): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Price
| Price | $2.17 |
| Market Cap | $10M |
| Exchange | NASDAQ |
| Country | US |
Financial Health
| Debt / Equity | -0.15 |
| Current Ratio | 0.19 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -97.60 |
Profitability
| Return on Equity | 892.52% |
| Return on Invested Capital | 120.87% |
| Return on Assets | -1300.98% |
| Gross Margin | -360.71% |
| Operating Margin | -46991.97% |
| Net Margin | -612568.11% |
Related companies: ADAP · ANL · APLM · BLRX · ERNA · GOVX · ICU
Explore sector: Healthcare · Biotechnology
More sections of LNAI: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks